Anheuser-Busch InBev SA/NV (BUDFF)
BUDFF is quoted over the counter, not listed on an exchange. Anheuser-Busch InBev SA/NV files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | BUDFF, quoted over the counter |
| SEC CIK | 0001668717 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Malt Beverages |
| Business address | Leuven |
| Incorporated in | Belgium |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-03-03 |
| Cash and burn | $11.6B cash; operating cash flow $3.7B a quarter. | Report 2025-12-31 |
| Shares outstanding | 1,797,199,994 (2025-12-31); 1,797,198,523 a year earlier; 1,737,191,283 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-05-30 |
| Auditor | PricewaterhouseCoopers Reviseurs d'Entreprises, Diegem, Belgium | PCAOB Form AP 2026-03-13 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $59.3B | $6.8B | $14.9B | $11.6B | $73.0B | $59.3B | 20-F 2026-03-03 |
| FY 2024 2024-12-31 | $59.8B | $5.9B | $15.1B | $11.2B | $72.2B | $59.8B | 20-F 2026-03-03 |
| FY 2023 2023-12-31 | $59.4B | $5.3B | $13.3B | $10.3B | No debt tags | $59.4B | 20-F 2026-03-03 |
| FY 2022 2022-12-31 | $57.8B | $6.0B | $13.3B | $10.0B | No debt tags | $57.8B | 20-F 2025-03-12 |
| FY 2021 2021-12-31 | $54.3B | $4.7B | $14.8B | $12.1B | No debt tags | $54.3B | 20-F 2024-03-11 |
| FY 2020 2020-12-31 | $46.9B | $1.4B | $10.9B | $15.3B | No debt tags | $46.9B | 20-F 2023-03-17 |
| FY 2019 2019-12-31 | $52.3B | $9.2B | $14.0B | $7.2B | $103.0B | $52.3B | 20-F 2022-03-18 |
| FY 2018 2018-12-31 | $53.0B | $4.4B | $15.1B | $7.1B | $111.6B | $53.0B | 20-F 2021-03-19 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-03-20 |
| Latest annual report | 20-F | 2026-03-03 |
| Latest quarterly / interim | 6-K | 2026-10-29 |
Source: SEC EDGAR submissions feed, 369 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier